The effect of oral glucose in pregnant wome
Not Applicable
- Conditions
- Pregnant women.Supervision of normal pregnancy
- Registration Number
- IRCT2012120111628N1
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 94
Inclusion Criteria
pregnant women; gestational ages between 32 to 40 weeks; singleton pregnancy; fetus without anomalies and exclusion criteria: hypertension and diabetes mellitus.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score bps include of Fetal breathing movements, fetal movements, fetal tone, fetal heart rate, speed, volume of amniotic fluid. Timepoint: Pre-intervention and post-intervention. Method of measurement: For each vaiable, if the patient has normal conditions then score of 2 is recorded. Otherwise, no score is recorded. The highest possible score for a natural birth rate of 10 and the lowest score is zero.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link oral glucose intake to fetal biophysical profile score changes in IRCT2012120111628N1?
How does oral glucose supplementation compare to standard antenatal care in predicting fetal distress outcomes?
Which maternal biomarkers correlate with improved biophysical profile scores after glucose administration in pregnancy?
What adverse events are associated with oral glucose testing in IRCT2012120111628N1 and how are they managed?
Are there alternative glucose monitoring strategies or combination therapies for optimizing fetal biophysical profiles in normal pregnancies?